Skip to content

Drug interactions

Nateglinide + Sparsentan

Severity: Moderate

Nateglinide and Sparsentan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sparsentan induces CYP2C9 and may lower exposure to CYP2C9 substrates such as nateglinide. This could reduce glucose-lowering efficacy.

What this interaction means in plain words

Nateglinide and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Nateglinide belongs to Endocrine; Sparsentan belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Induction of CYP2C9 increases nateglinide metabolism.

What to do

Monitor blood glucose after starting or stopping sparsentan and increase the nateglinide dose if control worsens.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nateglinide and Sparsentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nateglinide with Sparsentan?

MediHelp rates the interaction as moderate. Nateglinide and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sparsentan induces CYP2C9 and may lower exposure to CYP2C9 substrates such as nateglinide. This could reduce glucose-lowering efficacy.

How serious is the interaction between Nateglinide and Sparsentan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting or stopping sparsentan and increase the nateglinide dose if control worsens.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in